お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は遺伝性がん検査市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは遺伝性がん検査の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の遺伝性がん検査市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは遺伝性がん検査のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に遺伝性がん検査市場を分類しています。本研究に含まれる主な企業は：Ambry Genetics (Konica Minota)、Asper Biogene、Natera、Caris Life Sciences、BioReference Laboratories (GeneDx)、LabSolutions、Progenity，Inc、ARUP Laboratories、Myriad、NeoGenomics、Blueprint Genetics、CellMax Life、Fulgent Genetics、Strand Life Sciences、Myogenes、LabCorp、Quest Diagnostics、Pathway Genomics

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    RNA Testing
    DNA Testing

用途別の市場セグメント：
    Breast Cancer
    Gastrointestinal Cancer
    Prostate Cancer
    Respiratory/Lung Cancer
    Other Cancers

本レポートの詳細内容
世界の遺伝性がん検査市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、遺伝性がん検査タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の遺伝性がん検査収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の遺伝性がん検査市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、遺伝性がん検査市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

遺伝性がん検査のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：遺伝性がん検査のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：遺伝性がん検査の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章遺伝性がん検査企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：遺伝性がん検査の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：遺伝性がん検査の主要企業の概要を提供し、製品の説明と仕様、遺伝性がん検査の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Hereditary cancer testing is a process of identifying an inherited gene mutation that increases the risk of cancer development.  It mainly includes predictive genetic testing and clinical DNA sequencing, in predictive genetic testing, patient’s family history is analyzed for any inherited mutation from ancestry. In DNA sequencing, entire DNA or genome of an individual is analyzed. It is useful for testing many genetic mutations at a time.
Market Analysis and Insights: Global Hereditary Cancer Testing Market
The global Hereditary Cancer Testing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Hereditary Cancer Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Hereditary Cancer Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Hereditary Cancer Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Hereditary Cancer Testing include Ambry Genetics (Konica Minota), Asper Biogene, Natera, Caris Life Sciences, BioReference Laboratories (GeneDx), LabSolutions, Progenity，Inc, ARUP Laboratories and Myriad, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Hereditary Cancer Testing is widely used in various fields, such as Breast Cancer, Gastrointestinal Cancer, Prostate Cancer and Respiratory/Lung Cancer, etc. Breast Cancer provides greatest supports to the Hereditary Cancer Testing industry development. In 2023, global % revenue of Hereditary Cancer Testing went into Breast Cancer filed and the proportion will reach to % in 2030. 
Report Covers:
This report presents an overview of global market for Hereditary Cancer Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Hereditary Cancer Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Hereditary Cancer Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hereditary Cancer Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Hereditary Cancer Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Hereditary Cancer Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Ambry Genetics (Konica Minota), Asper Biogene, Natera, Caris Life Sciences, BioReference Laboratories (GeneDx), LabSolutions, Progenity，Inc, ARUP Laboratories and Myriad, etc.

Market Segmentation
By Company
    Ambry Genetics (Konica Minota)
    Asper Biogene
    Natera
    Caris Life Sciences
    BioReference Laboratories (GeneDx)
    LabSolutions
    Progenity，Inc
    ARUP Laboratories
    Myriad
    NeoGenomics
    Blueprint Genetics
    CellMax Life
    Fulgent Genetics
    Strand Life Sciences
    Myogenes
    LabCorp
    Quest Diagnostics
    Pathway Genomics

Segment by Type
    RNA Testing
    DNA Testing

Segment by Application
    Breast Cancer
    Gastrointestinal Cancer
    Prostate Cancer
    Respiratory/Lung Cancer
    Other Cancers

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Hereditary Cancer Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hereditary Cancer Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hereditary Cancer Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Hereditary Cancer Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of RNA Testing
    Table 3. Key Players of DNA Testing
    Table 4. Global Hereditary Cancer Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Hereditary Cancer Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Hereditary Cancer Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Hereditary Cancer Testing Market Share by Region (2019-2024)
    Table 8. Global Hereditary Cancer Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Hereditary Cancer Testing Market Share by Region (2025-2030)
    Table 10. Hereditary Cancer Testing Market Trends
    Table 11. Hereditary Cancer Testing Market Drivers
    Table 12. Hereditary Cancer Testing Market Challenges
    Table 13. Hereditary Cancer Testing Market Restraints
    Table 14. Global Hereditary Cancer Testing Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Hereditary Cancer Testing Revenue Share by Players (2019-2024)
    Table 16. Global Top Hereditary Cancer Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Cancer Testing as of 2023)
    Table 17. Global Hereditary Cancer Testing Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Hereditary Cancer Testing Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Hereditary Cancer Testing, Headquarters and Area Served
    Table 20. Global Key Players of Hereditary Cancer Testing, Product and Application
    Table 21. Global Key Players of Hereditary Cancer Testing, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Hereditary Cancer Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Hereditary Cancer Testing Revenue Market Share by Type (2019-2024)
    Table 25. Global Hereditary Cancer Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Hereditary Cancer Testing Revenue Market Share by Type (2025-2030)
    Table 27. Global Hereditary Cancer Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Hereditary Cancer Testing Revenue Share by Application (2019-2024)
    Table 29. Global Hereditary Cancer Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Hereditary Cancer Testing Revenue Share by Application (2025-2030)
    Table 31. North America Hereditary Cancer Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Hereditary Cancer Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Hereditary Cancer Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Hereditary Cancer Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Hereditary Cancer Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Hereditary Cancer Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Hereditary Cancer Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Hereditary Cancer Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Hereditary Cancer Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Hereditary Cancer Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Hereditary Cancer Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Hereditary Cancer Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Hereditary Cancer Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Hereditary Cancer Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Hereditary Cancer Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Hereditary Cancer Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Hereditary Cancer Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Hereditary Cancer Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Hereditary Cancer Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Hereditary Cancer Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Hereditary Cancer Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Hereditary Cancer Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Hereditary Cancer Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Hereditary Cancer Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Hereditary Cancer Testing Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Hereditary Cancer Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Hereditary Cancer Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Hereditary Cancer Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Hereditary Cancer Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Hereditary Cancer Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Hereditary Cancer Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Hereditary Cancer Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Ambry Genetics (Konica Minota) Company Details
    Table 64. Ambry Genetics (Konica Minota) Business Overview
    Table 65. Ambry Genetics (Konica Minota) Hereditary Cancer Testing Product
    Table 66. Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2019-2024) & (US$ Million)
    Table 67. Ambry Genetics (Konica Minota) Recent Developments
    Table 68. Asper Biogene Company Details
    Table 69. Asper Biogene Business Overview
    Table 70. Asper Biogene Hereditary Cancer Testing Product
    Table 71. Asper Biogene Revenue in Hereditary Cancer Testing Business (2019-2024) & (US$ Million)
    Table 72. Asper Biogene Recent Developments
    Table 73. Natera Company Details
    Table 74. Natera Business Overview
    Table 75. Natera Hereditary Cancer Testing Product
    Table 76. Natera Revenue in Hereditary Cancer Testing Business (2019-2024) & (US$ Million)
    Table 77. Natera Recent Developments
    Table 78. Caris Life Sciences Company Details
    Table 79. Caris Life Sciences Business Overview
    Table 80. Caris Life Sciences Hereditary Cancer Testing Product
    Table 81. Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2019-2024) & (US$ Million)
    Table 82. Caris Life Sciences Recent Developments
    Table 83. BioReference Laboratories (GeneDx) Company Details
    Table 84. BioReference Laboratories (GeneDx) Business Overview
    Table 85. BioReference Laboratories (GeneDx) Hereditary Cancer Testing Product
    Table 86. BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2019-2024) & (US$ Million)
    Table 87. BioReference Laboratories (GeneDx) Recent Developments
    Table 88. LabSolutions Company Details
    Table 89. LabSolutions Business Overview
    Table 90. LabSolutions Hereditary Cancer Testing Product
    Table 91. LabSolutions Revenue in Hereditary Cancer Testing Business (2019-2024) & (US$ Million)
    Table 92. LabSolutions Recent Developments
    Table 93. Progenity，Inc Company Details
    Table 94. Progenity，Inc Business Overview
    Table 95. Progenity，Inc Hereditary Cancer Testing Product
    Table 96. Progenity，Inc Revenue in Hereditary Cancer Testing Business (2019-2024) & (US$ Million)
    Table 97. Progenity，Inc Recent Developments
    Table 98. ARUP Laboratories Company Details
    Table 99. ARUP Laboratories Business Overview
    Table 100. ARUP Laboratories Hereditary Cancer Testing Product
    Table 101. ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2019-2024) & (US$ Million)
    Table 102. ARUP Laboratories Recent Developments
    Table 103. Myriad Company Details
    Table 104. Myriad Business Overview
    Table 105. Myriad Hereditary Cancer Testing Product
    Table 106. Myriad Revenue in Hereditary Cancer Testing Business (2019-2024) & (US$ Million)
    Table 107. Myriad Recent Developments
    Table 108. NeoGenomics Company Details
    Table 109. NeoGenomics Business Overview
    Table 110. NeoGenomics Hereditary Cancer Testing Product
    Table 111. NeoGenomics Revenue in Hereditary Cancer Testing Business (2019-2024) & (US$ Million)
    Table 112. NeoGenomics Recent Developments
    Table 113. Blueprint Genetics Company Details
    Table 114. Blueprint Genetics Business Overview
    Table 115. Blueprint Genetics Hereditary Cancer Testing Product
    Table 116. Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2019-2024) & (US$ Million)
    Table 117. Blueprint Genetics Recent Developments
    Table 118. CellMax Life Company Details
    Table 119. CellMax Life Business Overview
    Table 120. CellMax Life Hereditary Cancer Testing Product
    Table 121. CellMax Life Revenue in Hereditary Cancer Testing Business (2019-2024) & (US$ Million)
    Table 122. CellMax Life Recent Developments
    Table 123. Fulgent Genetics Company Details
    Table 124. Fulgent Genetics Business Overview
    Table 125. Fulgent Genetics Hereditary Cancer Testing Product
    Table 126. Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2019-2024) & (US$ Million)
    Table 127. Fulgent Genetics Recent Developments
    Table 128. Strand Life Sciences Company Details
    Table 129. Strand Life Sciences Business Overview
    Table 130. Strand Life Sciences Hereditary Cancer Testing Product
    Table 131. Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2019-2024) & (US$ Million)
    Table 132. Strand Life Sciences Recent Developments
    Table 133. Myogenes Company Details
    Table 134. Myogenes Business Overview
    Table 135. Myogenes Hereditary Cancer Testing Product
    Table 136. Myogenes Revenue in Hereditary Cancer Testing Business (2019-2024) & (US$ Million)
    Table 137. Myogenes Recent Developments
    Table 138. LabCorp Company Details
    Table 139. LabCorp Business Overview
    Table 140. LabCorp Hereditary Cancer Testing Product
    Table 141. LabCorp Revenue in Hereditary Cancer Testing Business (2019-2024) & (US$ Million)
    Table 142. LabCorp Recent Developments
    Table 143. Quest Diagnostics Company Details
    Table 144. Quest Diagnostics Business Overview
    Table 145. Quest Diagnostics Hereditary Cancer Testing Product
    Table 146. Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2019-2024) & (US$ Million)
    Table 147. Quest Diagnostics Recent Developments
    Table 148. Pathway Genomics Company Details
    Table 149. Pathway Genomics Business Overview
    Table 150. Pathway Genomics Hereditary Cancer Testing Product
    Table 151. Pathway Genomics Revenue in Hereditary Cancer Testing Business (2019-2024) & (US$ Million)
    Table 152. Pathway Genomics Recent Developments
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hereditary Cancer Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Hereditary Cancer Testing Market Share by Type: 2023 VS 2030
    Figure 3. RNA Testing Features
    Figure 4. DNA Testing Features
    Figure 5. Global Hereditary Cancer Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Hereditary Cancer Testing Market Share by Application: 2023 VS 2030
    Figure 7. Breast Cancer Case Studies
    Figure 8. Gastrointestinal Cancer Case Studies
    Figure 9. Prostate Cancer Case Studies
    Figure 10. Respiratory/Lung Cancer Case Studies
    Figure 11. Other Cancers Case Studies
    Figure 12. Hereditary Cancer Testing Report Years Considered
    Figure 13. Global Hereditary Cancer Testing Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Hereditary Cancer Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Hereditary Cancer Testing Market Share by Region: 2023 VS 2030
    Figure 16. Global Hereditary Cancer Testing Market Share by Players in 2023
    Figure 17. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Cancer Testing as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Hereditary Cancer Testing Revenue in 2023
    Figure 19. North America Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Hereditary Cancer Testing Market Share by Type (2019-2030)
    Figure 21. North America Hereditary Cancer Testing Market Share by Application (2019-2030)
    Figure 22. North America Hereditary Cancer Testing Market Share by Country (2019-2030)
    Figure 23. United States Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Hereditary Cancer Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Hereditary Cancer Testing Market Share by Type (2019-2030)
    Figure 27. Europe Hereditary Cancer Testing Market Share by Application (2019-2030)
    Figure 28. Europe Hereditary Cancer Testing Market Share by Country (2019-2030)
    Figure 29. Germany Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Hereditary Cancer Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Hereditary Cancer Testing Market Share by Type (2019-2030)
    Figure 37. China Hereditary Cancer Testing Market Share by Application (2019-2030)
    Figure 38. Asia Hereditary Cancer Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Hereditary Cancer Testing Market Share by Type (2019-2030)
    Figure 40. Asia Hereditary Cancer Testing Market Share by Application (2019-2030)
    Figure 41. Asia Hereditary Cancer Testing Market Share by Region (2019-2030)
    Figure 42. Japan Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Hereditary Cancer Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Hereditary Cancer Testing Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Hereditary Cancer Testing Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Hereditary Cancer Testing Market Share by Country (2019-2030)
    Figure 52. Brazil Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Hereditary Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Ambry Genetics (Konica Minota) Revenue Growth Rate in Hereditary Cancer Testing Business (2019-2024)
    Figure 59. Asper Biogene Revenue Growth Rate in Hereditary Cancer Testing Business (2019-2024)
    Figure 60. Natera Revenue Growth Rate in Hereditary Cancer Testing Business (2019-2024)
    Figure 61. Caris Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2019-2024)
    Figure 62. BioReference Laboratories (GeneDx) Revenue Growth Rate in Hereditary Cancer Testing Business (2019-2024)
    Figure 63. LabSolutions Revenue Growth Rate in Hereditary Cancer Testing Business (2019-2024)
    Figure 64. Progenity，Inc Revenue Growth Rate in Hereditary Cancer Testing Business (2019-2024)
    Figure 65. ARUP Laboratories Revenue Growth Rate in Hereditary Cancer Testing Business (2019-2024)
    Figure 66. Myriad Revenue Growth Rate in Hereditary Cancer Testing Business (2019-2024)
    Figure 67. NeoGenomics Revenue Growth Rate in Hereditary Cancer Testing Business (2019-2024)
    Figure 68. Blueprint Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2019-2024)
    Figure 69. CellMax Life Revenue Growth Rate in Hereditary Cancer Testing Business (2019-2024)
    Figure 70. Fulgent Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2019-2024)
    Figure 71. Strand Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2019-2024)
    Figure 72. Myogenes Revenue Growth Rate in Hereditary Cancer Testing Business (2019-2024)
    Figure 73. LabCorp Revenue Growth Rate in Hereditary Cancer Testing Business (2019-2024)
    Figure 74. Quest Diagnostics Revenue Growth Rate in Hereditary Cancer Testing Business (2019-2024)
    Figure 75. Pathway Genomics Revenue Growth Rate in Hereditary Cancer Testing Business (2019-2024)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed